close
Add to watchlist
Staar Surgical Co (STAA) Healthcare, Medical Equipment & Supplies
STAAR Surgical Company, together with its subsidiaries, develops, manufactures, and sells intraocular lenses (IOL), implantable collamer lenses (ICL), and ophthalmic surgical products used primarily in cataract and refractive surgery. The company's IOL products include silicone Toric IOL, which is used in cataract surgery for the treatment of preexisting astigmatism; The Preloaded Injector, a three-piece silicone or acrylic IOL preloaded into a single-use disposable injector; and Aspheric three-piece IOLs that provides a clearer image in low light. Its ICL products comprise the VISIAN ICL and VISIAN Toric ICL for the treatment of refractive disorders, such as myopia, hyperopia, and astigmatism. STAAR Surgical Company's ophthalmic surgical products consist of STAARVISC II, a viscoelastic material, which is used as a protective lubricant and to maintain the shape of the eye during surgery; Cruise Control, a single-use disposable filter that allows for a faster and cleaner phacoemulsification procedure; and the AquaFlow Collagen Glaucoma Drainage Device, an implantable device used for the surgical treatment of glaucoma. The company also distributes implantable lenses, related surgical equipment, consumables, and other supplies. It sells and markets its products to ophthalmologists and health care providers, including surgical centers, hospitals, managed care providers, health maintenance organizations, group purchasing organizations, and government facilities under the Visian, Collamer, STAARVISC, Elastimide, SonicWAVE, and AquaFlow brand names. STAAR Surgical Company operates in the United States, Switzerland, Japan, and Germany. The company was founded in 1982 and is headquartered in Monrovia, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 10.23 |
| Volume | 64091 |
| Volume Avg | 198297 |
| 52 Week High | 11.79 |
| 52 Week Low | 4.41 |
| PE | 257.00 |
| PE (group average) | 39 |
| EPS Year | 0.04 |
| EPS change Q/Q | -33.33% |
| EPS change Q/Q Yr ago | -50% |
| EPS change Q/Q next Q est | 1000% |
| EPS change Y/Y | 100% |
| REV change Q/Q | 9.09% |
| REV change Q/Q Yr ago | 8.27% |
| EPS next Q est | 0.02 |
| EPS next Y est | 0.19 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |